Hey@Andredamus1, what would you be choosing? NYSE or CDI's? This is assuming you keep holding.
I read yesterday's AFR article: "Explainer: How Square’s Afterpay takeover will affect the ASX". It made me think again about CDI's and the potential low liquidity one might get. However even if only 10% of Square ends up in CDI form (APT will make up about 18.5% of SQ) that would see a $20b CDI market cap assuming a SQ+APT market cap of $150B usd, enough to see the CDI remain in the ASX 50+, like Resmed. In that case liquidity would be more than enough even for large retail holdings.
APT Price at posting:
$126.99 Sentiment: Buy Disclosure: Held
